Efficacy of using 50 mL syringe manual thrombectomy catheter in patients with heavy thrombus burden undergoing primary percutaneous coronary intervention.
Arafa Gomaa Mohamed, Hamada Alsheikh, Mahmoud F Elshahat
{"title":"Efficacy of using 50 mL syringe manual thrombectomy catheter in patients with heavy thrombus burden undergoing primary percutaneous coronary intervention.","authors":"Arafa Gomaa Mohamed, Hamada Alsheikh, Mahmoud F Elshahat","doi":"10.5830/CVJA-2026-008","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Patients with ST-segment elevation myocardial infarction (STEMI) and heavy thrombus burden are at increased risk of distal embolisation and impaired reperfusion during primary percutaneous coronary intervention (PPCI). Conventional manual aspiration thrombectomy with a 30 mL syringe has shown limited benefit in large randomised trials. Increasing syringe volume to 50 mL may enhance suction efficiency and clot retrieval, offering a simple and cost-effective strategy to optimise reperfusion.</p><p><strong>Methods: </strong>In this prospective cohort study, 88 consecutive STEMI patients with angiographic thrombus burden grade 4-5 undergoing PPCI were included. Group I (n = 44) underwent thrombectomy with a 30 mL syringe, while Group II (n = 44) underwent thrombectomy with a 50 mL syringe using an Export Advance catheter. Primary endpoints were post-procedural thrombolysis in myocardial infarction (TIMI) 3 flow and myocardial blush grade (MBG). Secondary endpoints included ST-segment resolution, echocardiography recovery (wall motion score index [WMSI] and left ventricular ejection fraction [LVEF]), and 30-day adverse cardiovascular events.</p><p><strong>Results: </strong>Baseline clinical and laboratory characteristics were comparable between groups. The 50 mL syringe group achieved higher rates of complete reperfusion (TIMI 3 flow: 77% vs. 59%, p = 0.04; MBG 3: 59% vs. 45%, p = 0.05). The primary composite endpoint of TIMI 3 flow plus MBG 3 was significantly greater in Group II (59% vs. 41%, p = 0.04). ST-segment resolution (68 % 15% vs. 55 ± 12%, p = 0.01), immediate post-PCI WMSI (1.7 ± 0.4 vs. 2.1 ± 0.5, p = 0.002), one-month WMSI (1.5 ± 0.3 vs. 1.8 ± 0.4, p = 0.001), and LVEF (54 ± 5% vs. 49 ± 6%, p = 0.002) were all superior in the 50 mL group. At 30 days, cardiovascular events were numerically lower with the 50 mL syringe (2.3% vs. 4.1%, p = 0.17), with no increase in procedural complications.</p><p><strong>Conclusion: </strong>In STEMI patients with high thrombus burden undergoing PPCI, manual thrombectomy with a 50 mL syringe improved reperfusion, myocardial recovery, and procedural outcomes compared with the conventional 30 mL syringe, without added risk. This low-cost, accessible modification may represent a practical alternative to mechanical aspiration systems, warranting validation in larger randomised trials.</p>","PeriodicalId":9434,"journal":{"name":"Cardiovascular Journal of Africa","volume":"37 2","pages":"186-193"},"PeriodicalIF":0.7000,"publicationDate":"2026-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Journal of Africa","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5830/CVJA-2026-008","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Patients with ST-segment elevation myocardial infarction (STEMI) and heavy thrombus burden are at increased risk of distal embolisation and impaired reperfusion during primary percutaneous coronary intervention (PPCI). Conventional manual aspiration thrombectomy with a 30 mL syringe has shown limited benefit in large randomised trials. Increasing syringe volume to 50 mL may enhance suction efficiency and clot retrieval, offering a simple and cost-effective strategy to optimise reperfusion.
Methods: In this prospective cohort study, 88 consecutive STEMI patients with angiographic thrombus burden grade 4-5 undergoing PPCI were included. Group I (n = 44) underwent thrombectomy with a 30 mL syringe, while Group II (n = 44) underwent thrombectomy with a 50 mL syringe using an Export Advance catheter. Primary endpoints were post-procedural thrombolysis in myocardial infarction (TIMI) 3 flow and myocardial blush grade (MBG). Secondary endpoints included ST-segment resolution, echocardiography recovery (wall motion score index [WMSI] and left ventricular ejection fraction [LVEF]), and 30-day adverse cardiovascular events.
Results: Baseline clinical and laboratory characteristics were comparable between groups. The 50 mL syringe group achieved higher rates of complete reperfusion (TIMI 3 flow: 77% vs. 59%, p = 0.04; MBG 3: 59% vs. 45%, p = 0.05). The primary composite endpoint of TIMI 3 flow plus MBG 3 was significantly greater in Group II (59% vs. 41%, p = 0.04). ST-segment resolution (68 % 15% vs. 55 ± 12%, p = 0.01), immediate post-PCI WMSI (1.7 ± 0.4 vs. 2.1 ± 0.5, p = 0.002), one-month WMSI (1.5 ± 0.3 vs. 1.8 ± 0.4, p = 0.001), and LVEF (54 ± 5% vs. 49 ± 6%, p = 0.002) were all superior in the 50 mL group. At 30 days, cardiovascular events were numerically lower with the 50 mL syringe (2.3% vs. 4.1%, p = 0.17), with no increase in procedural complications.
Conclusion: In STEMI patients with high thrombus burden undergoing PPCI, manual thrombectomy with a 50 mL syringe improved reperfusion, myocardial recovery, and procedural outcomes compared with the conventional 30 mL syringe, without added risk. This low-cost, accessible modification may represent a practical alternative to mechanical aspiration systems, warranting validation in larger randomised trials.
背景:st段抬高型心肌梗死(STEMI)和血栓负担重的患者在原发性经皮冠状动脉介入治疗(PPCI)时远端栓塞和再灌注受损的风险增加。在大型随机试验中,使用30ml注射器的传统手动抽吸取栓显示出有限的益处。将注射器体积增加到50ml可以提高吸引效率和凝块回收,为优化再灌注提供了一种简单而经济的策略。方法:在这项前瞻性队列研究中,88例连续的STEMI血管造影血栓负担4-5级患者接受PPCI。I组(n = 44)采用30ml注射器取栓,II组(n = 44)采用50ml注射器取栓,采用Export Advance导管。主要终点是手术后心肌梗死溶栓(TIMI) 3血流和心肌红晕等级(MBG)。次要终点包括st段分辨率、超声心动图恢复(壁运动评分指数[WMSI]和左室射血分数[LVEF])和30天心血管不良事件。结果:两组之间的基线临床和实验室特征具有可比性。50ml注射组完全再灌注率更高(TIMI 3流量:77% vs. 59%, p = 0.04; MBG 3流量:59% vs. 45%, p = 0.05)。timi3血流加mbg3的主要复合终点在II组显著增加(59% vs. 41%, p = 0.04)。st段分辨率(68% - 15% vs. 55±12%,p = 0.01)、pci术后即刻WMSI(1.7±0.4 vs. 2.1±0.5,p = 0.002)、1个月WMSI(1.5±0.3 vs. 1.8±0.4,p = 0.001)、LVEF(54±5% vs. 49±6%,p = 0.002)均优于50 mL组。在30天,50ml注射器的心血管事件在数值上较低(2.3% vs. 4.1%, p = 0.17),没有增加手术并发症。结论:在接受PPCI的高血栓负荷STEMI患者中,与常规30ml注射器相比,50ml注射器手动取栓改善了再灌注、心肌恢复和手术结果,没有增加风险。这种低成本、可获得的修改可能是机械抽吸系统的一种实用替代方案,需要在更大规模的随机试验中进行验证。
期刊介绍:
The Cardiovascular Journal of Africa (CVJA) is an international peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital heart disease (fetal, paediatric and adult), heart failure, surgery, and basic science.